InvestorsHub Logo
Followers 64
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: flipper44 post# 417302

Sunday, 11/14/2021 9:02:25 AM

Sunday, November 14, 2021 9:02:25 AM

Post# of 704077
One rule of thumb that is generally followed is that you do not leave open a trial when you submit your package to FDA or they may tell you that they prefer to wait and get results from that active trial first. When your package is ready, you close the box, seal it and have it postmarked and signed for upon delivery.

I did not connect Direct to L in that way but do not disagree with that logic. Thanks, Flipper. It may have even been made clear to them that if you feel you are entitled to an accelerated path to proof with B, you connect the dots yourself to A and already have in our minds. It is a possibility and one that would likely be delivered in a way that does not allow you to publicly speak for FDA. This actually could work in your favor as you collect patents on everything. A good testing method to ensure as much uniformity as possible should be as complex and tightly controlled, validated, and assured before shipping not only to assure safety and efficacy, but also to protect technology. That too can be perfected in the meantime.

Looking at the glass and the water within is a better practice than looking at what is missing. Thinking about Phaciltate just tweeks me. There actually is a right way and wrong way to do some things and do them well. BUT there is a whole lot of water in that there glass.

Your possible explanation for what could go down as far as SNO also helps.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News